Fig. 5From: Genetic diversity and different cross-neutralization capability of porcine circovirus type 2 isolates recently circulating in South KoreaEvaluation of cross-protection capability (%VN) among different PCV2 genotypes. The anti-sera collected from guinea pigs vaccinated with Ingelvac CircoFLEX (a), QIA215 (b), QIA418 (c), QIA169 (d), and QIA244 (e) were neutralized with four PCV2 viruses: QIA215 (○), QIA418 (□), QIA169 (●), and QIA244 (■). Cross-protection efficiency among genotypes was evaluated using anti-sera of 1:2 to 1:8 SN titer against homologous viruses (dot line). *Significantly different from control at p < 0.05Back to article page